488 related articles for article (PubMed ID: 23033854)
21. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
Hagen F; Hare Jensen R; Meis JF; Arendrup MC
Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
[TBL] [Abstract][Full Text] [Related]
22. Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole.
Chang WN; Huang CR; Lei CB; Lee PY; Chien CC; Chang HW; Chang CS; Lu CH
Jpn J Infect Dis; 2004 Jun; 57(3):113-5. PubMed ID: 15218221
[TBL] [Abstract][Full Text] [Related]
23. Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002.
Sar B; Monchy D; Vann M; Keo C; Sarthou JL; Buisson Y
J Antimicrob Chemother; 2004 Aug; 54(2):563-5. PubMed ID: 15254027
[TBL] [Abstract][Full Text] [Related]
24. Genotypic diversity and antifungal susceptibility of Cryptococcus neoformans isolates from paediatric patients in China.
Hong N; Chen M; Xu N; Al-Hatmi AMS; Zhang C; Pan WH; Hagen F; Boekhout T; Xu J; Zou XB; Liao WQ
Mycoses; 2019 Feb; 62(2):171-180. PubMed ID: 30341799
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of antifungal combination against Cryptococcus spp.
Reichert-Lima F; Busso-Lopes AF; Lyra L; Peron IH; Taguchi H; Mikami Y; Kamei K; Moretti ML; Schreiber AZ
Mycoses; 2016 Sep; 59(9):585-93. PubMed ID: 27135278
[TBL] [Abstract][Full Text] [Related]
26. Antifungal susceptibility testing with YeastONE™ is not predictive of clinical outcomes of Cryptococcus neoformans var. grubii fungemia.
Yang JH; Huang PY; Cheng CW; Shie SS; Lin ZF; Yang LY; Lee CH; Wu TS
Med Mycol; 2021 Nov; 59(11):1114-1121. PubMed ID: 34374784
[TBL] [Abstract][Full Text] [Related]
27. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates from AIDS patients in Kenya.
Mdodo R; Moser SA; Jaoko W; Baddley J; Pappas P; Kempf MC; Aban I; Odera S; Jolly P
Mycoses; 2011 Sep; 54(5):e438-42. PubMed ID: 21535451
[TBL] [Abstract][Full Text] [Related]
28. Antifungal susceptibility, serotyping, and genotyping of clinical Cryptococcus neoformans isolates collected during 18 years in a single institution in Madrid, Spain.
Guinea J; Hagen F; Peláez T; Boekhout T; Tahoune H; Torres-Narbona M; Bouza E
Med Mycol; 2010 Nov; 48(7):942-8. PubMed ID: 20297948
[TBL] [Abstract][Full Text] [Related]
29. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S
J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
[TBL] [Abstract][Full Text] [Related]
30. Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
Córdoba S; Isla MG; Szusz W; Vivot W; Altamirano R; Davel G
Mycoses; 2016 Jun; 59(6):351-6. PubMed ID: 26865081
[TBL] [Abstract][Full Text] [Related]
31. Genotypic diversity in clinical and environmental isolates of Cryptococcus neoformans from India using multilocus microsatellite and multilocus sequence typing.
Prakash A; Sundar G; Sharma B; Hagen F; Meis JF; Chowdhary A
Mycoses; 2020 Mar; 63(3):284-293. PubMed ID: 31820495
[TBL] [Abstract][Full Text] [Related]
32. Molecular epidemiology and antifungal susceptibility profiles of clinical
Bandalizadeh Z; Shokohi T; Badali H; Abastabar M; Babamahmoudi F; Davoodi L; Mardani M; Javanian M; Cheraghmakani H; Sepidgar AA; Badiee P; Khodavaisy S; Afshari SAK; Ahmadikia K; Seyedmousavi S
J Med Microbiol; 2020 Jan; 69(1):72-81. PubMed ID: 31750814
[No Abstract] [Full Text] [Related]
33. [Molecular characterization of Cryptococcus neoformans isolates from HIV patients, Guayaquil, Ecuador].
Sánchez S; Zambrano D; García M; Bedoya C; Fernández C; Illnait-Zaragozí MT
Biomedica; 2017 Sep; 37(3):425-430. PubMed ID: 28968020
[TBL] [Abstract][Full Text] [Related]
34. In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India.
Chowdhary A; Randhawa HS; Sundar G; Kathuria S; Prakash A; Khan Z; Sun S; Xu J
J Med Microbiol; 2011 Jul; 60(Pt 7):961-967. PubMed ID: 21393452
[TBL] [Abstract][Full Text] [Related]
35. Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain.
Gago S; Serrano C; Alastruey-Izquierdo A; Cuesta I; Martín-Mazuelos E; Aller AI; Gómez-López A; Mellado E
Mycoses; 2017 Jan; 60(1):40-50. PubMed ID: 27633849
[TBL] [Abstract][Full Text] [Related]
36. Comparative typing analyses of clinical and environmental strains of the Cryptococcus neoformans/Cryptococcus gattii species complex from Ivory Coast.
Kassi FK; Bellet V; Drakulovski P; Krasteva D; Roger F; Valérie BA; Aboubakar T; Doumbia A; Kouakou GA; Delaporte E; Reynes J; Yavo W; Menan HIE; Bertout S
J Med Microbiol; 2018 Jan; 67(1):87-96. PubMed ID: 29214970
[TBL] [Abstract][Full Text] [Related]
37. Cryptococcal meningitis due to Cryptococcus neoformans genotype AFLP1/VNI in Iran: a review of the literature.
Badali H; Alian S; Fakhim H; Falahatinejad M; Moradi A; Mohammad Davoudi M; Hagen F; Meis JF
Mycoses; 2015 Dec; 58(12):689-93. PubMed ID: 26444438
[TBL] [Abstract][Full Text] [Related]
38. Extensive genetic diversity within the Dutch clinical Cryptococcus neoformans population.
Hagen F; Illnait-Zaragozí MT; Meis JF; Chew WH; Curfs-Breuker I; Mouton JW; Hoepelman AI; Spanjaard L; Verweij PE; Kampinga GA; Kuijper EJ; Boekhout T; Klaassen CH
J Clin Microbiol; 2012 Jun; 50(6):1918-26. PubMed ID: 22442325
[TBL] [Abstract][Full Text] [Related]
39. Serotyping of Cryptococcus neoformans strains isolated from clinical specimens in Thailand and their susceptibility to various antifungal agents.
Poonwan N; Mikami Y; Poosuwan S; Boon-Long J; Mekha N; Kusum M; Yazawa K; Tanaka R; Nishimura K; Konyama K
Eur J Epidemiol; 1997 Apr; 13(3):335-40. PubMed ID: 9258534
[TBL] [Abstract][Full Text] [Related]
40. Microbiological characteristics of clinical isolates of Cryptococcus spp. in Bahia, Brazil: molecular types and antifungal susceptibilities.
Matos CS; de Souza Andrade A; Oliveira NS; Barros TF
Eur J Clin Microbiol Infect Dis; 2012 Jul; 31(7):1647-52. PubMed ID: 22278291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
